SA cancer center to expand research diversity with national clinical trial
The Alamo City will play a key role in expanding and improving cancer research.
Full Article
SA cancer center to expand research diversity with national clinical trial
bizjournals
0 shares
1 views
You might like
Related news coverage
Q BioMed has a winner in cancer bone pain drug Strontium89 and a deep pipeline of biomedical assets
Proactive Investors
Acquires undervalued biomedical assets to accelerate their development Developing drugs and therapies to treat pediatric nonverbal..
-
Kazia Therapeutics makes strong progress with clinical programs for paxalisib and EVT801
Proactive Investors
-
BetterLife Pharma has a promising pipeline of psychedelic products, a coronavirus nebulizer and AP-001 cream
Proactive Investors
-
Chimeric Therapeutics accelerates development of CAR T therapy as it looks to boost pipeline with additional therapies
Proactive Investors
-
NA Proactive news snapshot: Progressive Planet, Real Luck Group, Deep-South Resources, Kidoz, Sigma Lithium UPDATE …
Proactive Investors
Advertisement
More coverage
NA Proactive news snapshot: Sigma Lithium Resources, Progressive Planet Solutions, NEO Battery Materials, Victory Square Technologies UPDATE …
Proactive Investors
Sigma Lithium Resources Corporation (CVE:SGMA) (OTCQB:SGMLF) has commenced significant earthworks activities at its Grota do Cirilo..
-
NA Proactive news snapshot: PharmaDrug, Vicinity Motor, Royal Road Minerals, Vox Royalty UPDATE …
Proactive Investors
-
NA Proactive news snapshot: Spotlite360 Technologies, BioHarvest Sciences, Kainantu Resources, KushCo Holdings, Nextleaf Solutions UPDATE …
Proactive Investors
-
NA Proactive news snapshot: BioHarvest Sciences, Kainantu Resources, KushCo Holdings, Nextleaf Solutions UPDATE …
Proactive Investors
-
Avalon GloboCare inks definitive agreement to acquire Chinese cell therapy company Senlang Biotechnology
Proactive Investors